Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) EBT Margin: 2014-2024

Historic EBT Margin for Collegium Pharmaceutical (COLL) over the last 11 years, with Dec 2024 value amounting to 15.61%.

  • Collegium Pharmaceutical's EBT Margin rose 1097.00% to 20.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.68%, marking a year-over-year decrease of 1068.00%. This contributed to the annual value of 15.61% for FY2024, which is 225.00% up from last year.
  • Collegium Pharmaceutical's EBT Margin amounted to 15.61% in FY2024, which was up 16.82% from 13.36% recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's EBT Margin ranged from a high of 15.61% in FY2024 and a low of -6.22% during FY2022.
  • Its 3-year average for EBT Margin is 7.58%, with a median of 13.36% in 2023.
  • As far as peak fluctuations go, Collegium Pharmaceutical's EBT Margin crashed by 1,012bps in 2021, and later soared by 1,958bps in 2023.
  • Yearly analysis of 5 years shows Collegium Pharmaceutical's EBT Margin stood at 8.90% in 2020, then crashed by 1,012bps to -1.22% in 2021, then tumbled by 500bps to -6.22% in 2022, then skyrocketed by 1,958bps to 13.36% in 2023, then spiked by 225bps to 15.61% in 2024.